Role of the cytoskeleton in communication between L-type Ca2+ channels and mitochondria

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 4, 2013, Pages 295-304

  Viola, Helena M ^a   Hool, Livia C ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cardiac hypertrophy; Cytoskeleton; Mitochondria; Voltage dependent anion channel

Indexed keywords

CALCIUM CHANNEL; CYTOSKELETON PROTEIN; REACTIVE OXYGEN METABOLITE; VOLTAGE DEPENDENT ANION CHANNEL; CALCIUM; CALCIUM CHANNEL L TYPE;

ARTICLE; CALCIUM TRANSPORT; CARDIOMYOPATHY; CELL COMMUNICATION; CELL FUNCTION; CELL MEMBRANE; CELL ORGANELLE; CYTOSKELETON; HEART CONTRACTION; HEART EXCITATION; HEART MUSCLE CELL; HUMAN; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; CHEMISTRY; HEART; HEART DISEASE; HEART MITOCHONDRION; METABOLISM; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE;

CALCIUM; CALCIUM CHANNELS, L-TYPE; CARDIOMYOPATHIES; CYTOSKELETON; HEART; HEART DISEASES; HUMANS; MITOCHONDRIA, HEART;

EID: 84875658663     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12072     Document Type: Article

References (133)

1. Bers DM. Cardiac excitation-contraction coupling. Nature 2002; 415: 198-205.
2. Hool LC, Corry B. Redox control of calcium channels: from mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2007; 9: 409-35.
3. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu. Rev. Physiol. 2008; 70: 23-49.
4. Carafoli E, Santella L, Branca D, Brini M. Generation, control, and processing of cellular calcium signals. Crit. Rev. Biochem. Mol. Biol. 2001; 36: 107-260.
5. Bodi I, Mikala G, Koch SE, Akhter SA, Schwartz A. The L-type calcium channel in the heart: the beat goes on. J. Clin. Invest. 2005; 115: 3306-17.
6. Bezprozvanny I, Watras J, Ehrlich BE. Bell-shaped calcium-response curves of Ins(1, 4, 5)P3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 1991; 351: 751-4.
7. Luo D, Yang D, Lan X et al. Nuclear Ca2+ sparks and waves mediated by inositol 1, 4, 5-trisphosphate receptors in neonatal rat cardiomyocytes. Cell Calcium 2008; 43: 165-74.
8. Bare DJ, Kettlun CS, Liang M, Bers DM, Mignery GA. Cardiac type 2 inositol 1, 4, 5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J. Biol. Chem. 2005; 280: 15912-20.
9. Lipp P, Laine M, Tovey SC et al. Functional InsP3 receptors that may modulate excitation-contraction coupling in the heart. Curr. Biol. 2000; 10: 939-42.
10. Kentish JC, Barsotti RJ, Lea TJ, Mulligan IP, Patel JR, Ferenczi MA. Calcium release from cardiac sarcoplasmic reticulum induced by photorelease of calcium or Ins (1, 4, 5) P3. Am. J. Physiol. Heart Circ. Physiol. 1990; 258: H610-5.
11. Domeier TL, Zima AV, Maxwell JT, Huke S, Mignery GA, Blatter LA. IP3 receptor-dependent Ca2+ release modulates excitation-contraction coupling in rabbit ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 2008; 294: H596-604.
12. Jurkat-Rott K, Lehmann-Horn F. The impact of splice isoforms on voltage-gated calcium channel α1 subunits. J. Physiol. 2004; 554: 609-19.
13. Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu. Rev. Cell Dev. Biol. 2000; 16: 521-55.
14. Takahashi M, Catterall WA. Dihydropyridine-sensitive calcium channels in cardiac and skeletal muscle membranes: studies with antibodies against the α subunits. Biochemistry 1987; 26: 5518-26.
15. De Jongh KS, Warner C, Catterall WA. Subunits of purified calcium channels. α2 and δ are encoded by the same gene. J. Biol. Chem. 1990; 265: 14738-41.
16. Jay SD, Sharp AH, Kahl SD, Vedvick TS, Harpold MM, Campbell KP. Structural characterization of the dihydropyridine-sensitive calcium channel α2-subunit and the associated δ peptides. J. Biol. Chem. 1991; 266: 3287-93.
17. Klugbauer N, Lacinova L, Marais E, Hobom M, Hofmann F. Molecular diversity of the calcium channel α2δ subunit. J. Neurosci. 1999; 19: 684-91.
18. Gurnett CA, De Waard M, Campbell KP. Dual function of the voltage-dependent Ca2+ channel α2δ subunit in current stimulation and subunit interaction. Neuron 1996; 16: 431-40.
19. Felix R, Gurnett CA, De Waard M, Campbell KP. Dissection of functional domains of the voltage-dependent Ca2+ channel α2δ subunit. J. Neurosci. 1997; 17: 6884-91.
20. Pragnell M, De Waard M, Mori Y, Tanabe T, Snutch TP, Campbell KP. Calcium channel β-subunit binds to a conserved motif in the I-II cytoplasmic linker of the α1-subunit. Nature 1994; 368: 67-70.
21. Dolphin AC. β subunits of voltage-gated calcium channels. J. Bioenerg. Biomembr. 2003; 35: 599-620.
22. Sucharov CC, Mariner PD, Nunley KR, Long C, Leinwand L, Bristow MR. A β1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am. J. Physiol. Heart Circ. Physiol. 2006; 291: H1299-308.
23. Bodi I, Muth JN, Hahn HS et al. Electrical remodeling in hearts from a calcium-dependent mouse model of hypertrophy and failure. Complex nature of K+ current changes and action potential duration. J. Am. Coll. Cardiol. 2003; 41: 1611-22.
24. Zobel C, Rana OR, Saygili E et al. Mechanisms of Ca2+-dependent calcineurin activation in mechanical stretch-induced hypertrophy. Cardiology 2007; 107: 281-90.
25. Nakayama H, Chen X, Baines CP et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J. Clin. Invest. 2007; 117: 2431-44.
26. Haase H, Kresse A, Hohaus A et al. Expression of calcium channel subunits in the normal and diseased human myocardium. J. Mol. Med. 1996; 74: 99-104.
27. Splawski I, Timothy KW, Decher N et al. Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl Acad. Sci. USA 2005; 102: 8089-96.
28. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Annu. Rev. Physiol. 2003; 65: 45-79.
29. Berridge MJ. Calcium microdomains: organization and function. Cell Calcium 2006; 40: 405-12.
30. Lompre AM, Schwartz K, d'Albis A, Lacombe G, Van Thiem N, Swynghedauw B. Myosin isoenzyme redistribution in chronic heart overload. Nature 1979; 282: 105-7.
31. Mann DL, Bristow MR. Mechanisms and models in heart failure. The biomechanical model and beyond. Circulation 2005; 111: 2837-49.
32. Semsarian C, Ahmad I, Giewat M et al. The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model. J. Clin. Invest. 2002; 109: 1013-20.
33. Balaban RS. Cardiac energy metabolism homeostasis: role of cytosolic calcium. J. Mol. Cell. Cardiol. 2002; 34: 1259-71.
34. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS. A mitochondrial love-hate triangle. Am. J. Physiol. Cell Physiol. 2004; 287: C817-33.
35. Baughman JM, Perocchi F, Girgis HS et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 2011; 476: 341-5.
36. De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto RA. Forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 2011; 476: 336-40.
37. Maack C, Cortassa S, Aon MA, Ganesan AN, Liu T, O'Rourke B. Elevated cytosolic Na+ decreases mitochondrial Ca2+ uptake during excitation-contraction coupling and impairs energetic adaptation in cardiac myocytes. Circ. Res. 2006; 99: 172-82.
38. Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 2004; 427: 360-4.
39. Palty R, Silverman WF, Hershfinkel M et al. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc. Natl Acad. Sci. USA 2010; 107: 436-41.
40. Sheeran FL, Pepe S. Energy deficiency in the failing heart: linking increased reactive oxygen species and disruption of oxidative phosphorylation rate. Biochim. Biophys. Acta 2006; 1757: 543-52.
41. Cortassa S, Aon MA, Marban E, Winslow RL, O'Rourke B. An integrated model of cardiac mitochondrial energy metabolism and calcium dynamics. Biophys. J. 2003; 84: 2734-55.
42. Rutter GA, Denton RM. Regulation of NAD+-linked isocitrate dehydrogenase and 2-oxoglutarate dehydrogenase by Ca2+ ions within toluene-permeabilized rat heart mitochondria. Interactions with regulation by adenine nucleotides and NADH/NAD+ ratios. Biochem. J. 1988; 252: 181-9.
43. McCormack JG, Denton RM. Role of Ca2+ ions in the regulation of intramitochondrial metabolism in rat heart. Evidence from studies with isolated mitochondria that adrenaline activates the pyruvate dehydrogenase and 2-oxoglutarate dehydrogenase complexes by increasing the intramitochondrial concentration of Ca2+. Biochem. J. 1984; 218: 235-47.
44. Nichols BJ, Rigoulet M, Denton RM. Comparison of the effects of Ca2+, adenine nucleotides and pH on the kinetic properties of mitochondrial NAD+-isocitrate dehydrogenase and oxoglutarate dehydrogenase from the yeast Saccharomyces cerevisiae and rat heart. Biochem. J. 1994; 303: 461-5.
45. McCormack JG, Halestrap AP, Denton RM. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol. Rev. 1990; 70: 391-425.
46. Hansford RG, Zorov D. Role of mitochondrial calcium transport in the control of substrate oxidation. Mol. Cell. Biochem. 1998; 184: 359-69.
47. Aon MA, Cortassa S, Marban E, O'Rourke B. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J. Biol. Chem. 2003; 278: 44735-44.
48. Territo PR, Mootha VK, French SA, Balaban RS. Ca2+ activation of heart mitochondrial oxidative phosphorylation: role of the F0/F1-ATPase. Am. J. Physiol. Cell Physiol. 2000; 278: C423-35.
49. Turrens JF. Mitochondrial formation of reactive oxygen species. J. Physiol. 2003; 552: 335-44.
50. Liochev SI, Fridovich I. Superoxide and iron: partners in crime. IUBMB Life 1999; 48: 157-61.
51. Gunter TE, Sheu SS. Characteristics and possible functions of mitochondrial Ca2+ transport mechanisms. Biochim. Biophys. Acta 2009; 1787: 1291-308.
52. Sheu SS, Nauduri D, Anders MW. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim. Biophys. Acta 2006; 1762: 256-65.
53. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000; 279: L1005-28.
54. Stone JR, Yang S. Hydrogen peroxide: a signaling messenger. Antioxid. Redox Signal. 2006; 8: 243-70.
55. Turrens JF. Superoxide production by the mitochondrial respiratory chain. Biosci. Rep. 1997; 17: 3-8.
56. Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 1995; 64: 97-112.
57. Graham D, Huynh NN, Hamilton CA et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009; 54: 322-8.
58. Andreyev AY, Kushnareva YE, Starkov AA. Mitochondrial metabolism of reactive oxygen species. Biochemistry 2005; 70: 200-14.
59. Murphy MP. How mitochondria produce reactive oxygen species. Biochem. J. 2009; 417: 1-13.
60. Droge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002; 82: 47-95.
61. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993; 23(Suppl. 1): 118-26.
62. Murdoch CE, Zhang M, Cave AC, Shah AM. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc. Res. 2006; 71: 208-15.
63. Sawyer DB, Siwik DA, Xiao L, Pimentel DR, Singh K, Colucci WS. Role of oxidative stress in myocardial hypertrophy and failure. J. Mol. Cell. Cardiol. 2002; 34: 379-88.
64. Giordano FJ. Oxygen, oxidative stress, hypoxia, and heart failure. J. Clin. Invest. 2005; 115: 500-8.
65. Sabri A, Hughie HH, Lucchesi PA. Regulation of hypertrophic and apoptotic signaling pathways by reactive oxygen species in cardiac myocytes. Antioxid. Redox Signal. 2003; 5: 731-40.
66. Bolli R. Causative role of oxyradicals in myocardial stunning: a proven hypothesis. A brief review of the evidence demonstrating a major role of reactive oxygen species in several forms of postischemic dysfunction. Basic Res. Cardiol. 1998; 93: 156-62.
67. Grieve DJ, Byrne JA, Cave AC, Shah AM. Role of oxidative stress in cardiac remodelling after myocardial infarction. Heart Lung Circ. 2004; 13: 132-8.
68. Hool LC. Reactive oxygen species in cardiac signalling: from mitochondria to plasma membrane ion channels. Clin. Exp. Pharmacol. Physiol. 2006; 33: 146-51.
69. Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem. Biophys. Res. Commun. 2004; 322: 1178-91.
70. van Empel VP, De Windt LJ. Myocyte hypertrophy and apoptosis: a balancing act. Cardiovasc. Res. 2004; 63: 487-99.
71. Ruwhof C, van der Laarse A. Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc. Res. 2000; 47: 23-37.
72. Dorn GW 2nd, Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 2005; 115: 527-37.
73. Newton AC. Protein kinase C: structure, function, and regulation. J. Biol. Chem. 1995; 270: 28495-8.
74. Wang J, Liu X, Arneja AS, Dhalla NS. Alterations in protein kinase A and protein kinase C levels in heart failure due to genetic cardiomyopathy. Can. J. Cardiol. 1999; 15: 683-90.
75. McKinsey TA. Derepression of pathological cardiac genes by members of the CaM kinase superfamily. Cardiovasc. Res. 2007; 73: 667-77.
76. Malhotra A, Kang BP, Opawumi D, Belizaire W, Meggs LG. Molecular biology of protein kinase C signaling in cardiac myocytes. Mol. Cell. Biochem. 2001; 225: 97-107.
77. Poole AW, Pula G, Hers I, Crosby D, Jones ML. PKC-interacting proteins: from function to pharmacology. Trends Pharmacol. Sci. 2004; 25: 528-35.
78. Wilkins BJ, Molkentin JD. Calcineurin and cardiac hypertrophy: where have we been? Where are we going? J. Physiol. 2002; 541: 1-8.
79. Kowaltowski AJ, Vercesi AE. Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 1999; 26: 463-71.
80. Boveris A, Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 1973; 134: 707-16.
81. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 2000; 29: 222-30.
82. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase. Role in cardiovascular biology and disease. Circ. Res. 2000; 86: 494-501.
83. Viola HM, Arthur PG, Hool LC. Transient exposure to hydrogen peroxide causes an increase in mitochondria-derived superoxide as a result of sustained alteration in L-type Ca2+ channel function in the absence of apoptosis in ventricular myocytes. Circ. Res. 2007; 100: 1036-44.
84. Hool LC, Di Maria CA, Viola HM, Arthur PG. Role of NAD(P)H oxidase in the regulation of cardiac L-type Ca2+ channel function during acute hypoxia. Cardiovasc. Res. 2005; 67: 624-35.
85. Rappaport L, Oliviero P, Samuel JL. Cytoskeleton and mitochondrial morphology and function. Mol. Cell. Biochem. 1998; 184: 101-5.
86. Penman S. Rethinking cell structure. Proc. Natl Acad. Sci. USA 1995; 92: 5251-7.
87. Wang N, Ingber DE. Control of cytoskeletal mechanics by extracellular matrix, cell shape, and mechanical tension. Biophys. J. 1994; 66: 2181-9.
88. Galli A, DeFelice LJ. Inactivation of L-type Ca channels in embryonic chick ventricle cells: dependence on the cytoskeletal agents colchicine and taxol. Biophys. J. 1994; 67: 2296-304.
89. Rueckschloss U, Isenberg G. Cytochalasin D reduces Ca2+ currents via cofilin-activated depolymerization of F-actin in guinea-pig cardiomyocytes. J. Physiol. 2001; 537: 363-70.
90. Lader AS, Kwiatkowski DJ, Cantiello HF. Role of gelsolin in the actin filament regulation of cardiac L-type calcium channels. Am. J. Physiol. Cell Physiol. 1999; 277: C1277-83.
91. Woolf PJ, Lu S, Cornford-Nairn R et al. Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle. Am. J. Physiol. Heart Circ. Physiol. 2006; 290: H2439-45.
92. Schubert T, Akopian A. Actin filaments regulate voltage-gated ion channels in salamander retinal ganglion cells. Neuroscience 2004; 125: 583-90.
93. Nakamura M, Sunagawa M, Kosugi T, Sperelakis N. Actin filament disruption inhibits L-type Ca2+ channel current in cultured vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2000; 279: C480-7.
94. Sadeghi A, Doyle AD, Johnson BD. Regulation of the cardiac L-type Ca2+ channel by the actin-binding proteins α-actinin and dystrophin. Am. J. Physiol. Cell Physiol. 2002; 282: C1502-11.
95. Viola HM, Arthur PG, Hool LC. Evidence for regulation of mitochondrial function by the L-type Ca2+ channel in ventricular myocytes. J. Mol. Cell. Cardiol. 2009; 46: 1016-26.
96. Hohaus A, Person V, Behlke J, Schaper J, Morano I, Haase H. The carboxyl-terminal region of ahnak provides a link between cardiac L-type Ca2+ channels and the actin-based cytoskeleton. FASEB J. 2002; 16: 1205-16.
97. Alvarez J, Hamplova J, Hohaus A, Morano I, Haase H, Vassort G. Calcium current in rat cardiomyocytes is modulated by the carboxyl-terminal ahnak domain. J. Biol. Chem. 2004; 279: 12456-61.
98. Haase H, Alvarez J, Petzhold D et al. Ahnak is critical for cardiac Cav1.2 calcium channel function and its β-adrenergic regulation. FASEB J. 2005; 19: 1969-77.
99. Jung C, Martins AS, Niggli E, Shirokova N. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. Cardiovasc. Res. 2008; 77: 766-73.
100. Danialou G, Comtois AS, Dudley R et al. Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury. FASEB J. 2001; 15: 1655-7.
101. Hainsey TA, Senapati S, Kuhn DE, Rafael JA. Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature. Neuromuscul. Disord. 2003; 13: 294-302.
102. Emery AE. The muscular dystrophies. Lancet 2002; 359: 687-95.
103. Boland BJ, Silbert PL, Groover RV, Wollan PC, Silverstein MD. Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. Pediatr. Neurol. 1996; 14: 7-12.
104. Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul. Disord. 2002; 12: 926-9.
105. Hunsaker RH, Fulkerson PK, Barry FJ, Lewis RP, Leier CV, Unverferth DV. Cardiac function in Duchenne's muscular dystrophy. Results of 10-year follow-up study and noninvasive tests. Am. J. Med. 1982; 73: 235-8.
106. Hunter S. The heart in muscular dystrophy. Br. Med. Bull. 1980; 36: 133-4.
107. Melacini P, Vianello A, Villanova C et al. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscul. Disord. 1996; 6: 367-76.
108. Koenig X, Dysek S, Kimbacher S et al. Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart. PLoS One 2011; 6: e20300.
109. Heggeness MH, Simon M, Singer SJ. Association of mitochondria with microtubules in cultured cells. Proc. Natl Acad. Sci. USA 1978; 75: 3863-6.
110. Leterrier JF, Rusakov DA, Linden M. Statistical analysis of the surface distribution of microtubule-associated proteins (MAPs) bound in vitro to rat brain mitochondria and labelled by 10 nm gold-coupled antibodies. Bull. Assoc. Anat. 1994; 78: 47-51.
111. Ball EH, Singer SJ. Mitochondria are associated with microtubules and not with intermediate filaments in cultured fibroblasts. Proc. Natl Acad. Sci. USA 1982; 79: 123-6.
112. Capetanaki Y. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. Trends Cardiovasc. Med. 2002; 12: 339-48.
113. Reipert S, Steinbock F, Fischer I, Bittner RE, Zeold A, Wiche G. Association of mitochondria with plectin and desmin intermediate filaments in striated muscle. Exp. Cell Res. 1999; 252: 479-91.
114. Milner DJ, Mavroidis M, Weisleder N, Capetanaki Y. Desmin cytoskeleton linked to muscle mitochondrial distribution and respiratory function. J. Cell Biol. 2000; 150: 1283-98.
115. Maloyan A, Sanbe A, Osinska H et al. Mitochondrial dysfunction and apoptosis underlie the pathogenic process in α-B-crystallin desmin-related cardiomyopathy. Circulation 2005; 112: 3451-61.
116. Saetersdal T, Greve G, Dalen H. Associations between β-tubulin and mitochondria in adult isolated heart myocytes as shown by immunofluorescence and immunoelectron microscopy. Histochemistry 1990; 95: 1-10.
117. Drubin DG, Jones HD, Wertman KF. Actin structure and function: roles in mitochondrial organization and morphogenesis in budding yeast and identification of the phalloidin-binding site. Mol. Biol. Cell 1993; 4: 1277-94.
118. Morris RL, Hollenbeck PJ. Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons. J. Cell Biol. 1995; 131: 1315-26.
119. Varadi A, Johnson-Cadwell LI, Cirulli V, Yoon Y, Allan VJ, Rutter GA. Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1. J. Cell Sci. 2004; 117: 4389-400.
120. Olson TM, Doan TP, Kishimoto NY, Whitby FG, Ackerman MJ, Fananapazir L. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 2000; 32: 1687-94.
121. Dhalla NS, Dent MR, Tappia PS, Sethi R, Barta J, Goyal RK. Subcellular remodeling as a viable target for the treatment of congestive heart failure. J. Cardiovasc. Pharmacol. Ther. 2006; 11: 31-45.
122. Khairallah M, Khairallah R, Young ME, Dyck JR, Petrof BJ, Des Rosiers C. Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. J. Mol. Cell. Cardiol. 2007; 43: 119-29.
123. Cingolani E, Ramirez Correa GA, Kizana E, Murata M, Cheol Cho H, Marban E. Gene therapy to inhibit the calcium channel β subunit. Physiological consequences and pathophysiological effects in models of cardiac hypertrophy. Circ. Res. 2007; 101: 166-75.
124. Kobrinsky E, Tiwari S, Maltsev VA et al. Differential role of the α1C subunit tails in regulation of the Cav1.2 channel by membrane potential, β subunits, and Ca2+ ions. J. Biol. Chem. 2005; 280: 12474-85.
125. Crompton M, Virji S, Ward JM. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 1998; 258: 729-35.
126. Sampson MJ, Lovell RS, Craigen WJ. The murine voltage-dependent anion channel gene family. Conserved structure and function. J. Biol. Chem. 1997; 272: 18.
127. Rostovtseva TK, Bezrukov SM. VDAC regulation: role of cytosolic proteins and mitochondrial lipids. J. Bioenerg. Biomembr. 2008; 40: 163-70.
128. Rostovtseva T, Colombini M. VDAC channels mediate and gate the flow of ATP. Implications for the regulation of mitochondrial function. Biophys. J. 1997; 72: 1954-62.
129. Rostovtseva T, Colombini M. ATP flux is controlled by a voltage-gated channel from the mitochondrial outer membrane. J. Biol. Chem. 1996; 271: 28006-8.
130. Kay L, Li Z, Mericskay M et al. Study of regulation of mitochondrial respiration in vivo. An analysis of influence of ADP diffusion and possible role of cytoskeleton. Biochim. Biophys. Acta 1997; 1322: 41-59.
131. Rostovtseva TK, Sheldon KL, Hassanzadeh E et al. Tubulin binding blocks mitochondrial voltage-dependent anion channel and regulates respiration. Proc. Natl Acad. Sci. USA 2008; 105: 18746-51.
132. Zhai P, Sadoshima J. Overcoming an energy crisis?:An adaptive role of glycogen synthase kinase-3 inhibition in ischemia/reperfusion. Circ. Res. 2008; 103: 910-3.
133. Das S, Wong R, Rajapakse N, Murphy E, Steenbergen C. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ. Res. 2008; 103: 983-91.